Addex Therapeutics (ADXN) Short Interest Ratio & Short Volume $8.40 -0.10 (-1.18%) As of 11:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Addex Therapeutics Short Interest DataAddex Therapeutics (ADXN) has a short interest of 2,900 shares, representing 0.35% of the float (the number of shares available for trading by the public). This marks a 45.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 92,333 shares to cover all short positions.Current Short Interest2,900 sharesPrevious Short Interest2,000 sharesChange Vs. Previous Month+45.00%Dollar Volume Sold Short$22,591.00Short Interest Ratio0.4 Days to CoverLast Record DateApril 30, 2025Outstanding Shares1,060,000 sharesFloat Size819,300 sharesShort Percent of Float0.35%Today's Trading Volume1,077 sharesAverage Trading Volume92,333 sharesToday's Volume Vs. Average1% Short Selling Addex Therapeutics? Sign up to receive the latest short interest report for Addex Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartADXN Short Interest Over TimeADXN Days to Cover Over TimeADXN Percentage of Float Shorted Over Time Addex Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20252,900 shares $22,591.00 +45.0%0.4%0.4 $7.79 4/15/20252,000 shares $14,600.00 -44.4%0.2%0.2 $7.30 3/31/20253,600 shares $26,424.00 +227.3%0.4%0.2 $7.34 3/15/20251,100 shares $8,057.50 -15.4%0.1%0.1 $7.33 2/28/20251,300 shares $11,050.00 -23.5%0.2%0.1 $8.50 2/15/20251,700 shares $12,741.50 +13.3%0.2%0.1 $7.50 1/31/20251,500 shares $11,550.00 -54.6%0.2%0 $7.70 1/15/20253,300 shares $25,030.50 -42.1%0.4%0.1 $7.59 12/31/20245,700 shares $39,900.00 -34.5%0.7%0.1 $7.00 12/15/20248,700 shares $69,600.00 -43.1%1.1%0.2 $8.00 Get the Latest News and Ratings for ADXN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/202415,300 shares $133,263.00 -16.9%1.9%0.3 $8.71 11/15/202418,400 shares $148,304.00 +425.7%2.3%0.1 $8.06 10/31/20243,500 shares $34,125.00 -64.7%0.4%0 $9.75 10/15/20249,900 shares $103,455.00 +3.1%1.2%0 $10.45 9/30/20249,600 shares $93,792.00 -62.2%1.2%0 $9.77 9/15/202425,400 shares $244,856.00 -74.0%3.1%0.1 $9.64 8/31/202497,500 shares $1.06 million +9,650.0%11.9%0.4 $10.86 8/15/20241,000 shares $7,800.00 -23.1%0.1%0.3 $7.80 7/31/20241,300 shares $10,855.00 -23.5%0.2%0.4 $8.35 7/15/20241,700 shares $14,144.00 -39.3%0.2%0.2 $8.32 6/30/20242,800 shares $23,016.56 -40.4%0.3%0.2 $8.22 6/15/20244,700 shares $40,467.00 -27.7%0.6%0.3 $8.61 5/31/20246,500 shares $55,900.00 +18.2%0.8%0.3 $8.60 5/15/20245,500 shares $49,500.00 -62.6%0.7%0.3 $9.00 4/30/202414,700 shares $112,455.00 -32.3%1.9%0.8 $7.65 4/15/202421,700 shares $537,075.00 +149.4%2.7%1.3 $24.75 3/31/20248,700 shares $111,360.00 -26.9%0.9%0.5 $12.80 3/15/202411,900 shares $139,349.00 +41.7%1.2%1.2 $11.71 2/29/20248,400 shares $79,884.00 +33.3%0.8%0.9 $9.51 2/15/20246,300 shares $66,087.00 -27.6%0.6%0.7 $10.49 1/31/20248,700 shares $94,308.00 +222.2%0.9%0.8 $10.84 1/15/20242,700 shares $18,765.00 +12.5%0.3%0.3 $6.95 12/31/20232,400 shares $14,520.00 -33.3%0.2%0.2 $6.05 12/15/20233,600 shares $19,548.00 -14.3%0.4%0.4 $5.43 11/30/20234,200 shares $23,310.00 -25.0%0.5%0.5 $5.55 11/15/20235,600 shares $34,160.00 +5.7%0.8%0.8 $6.10 10/31/20235,300 shares $33,337.00 No Change0.8%1 $6.29 10/15/20235,300 shares $43,036.00 -95.4%N/A1.3 $8.12 9/30/2023115,900 shares $44,540.37 -35.0%N/A1.7 $0.38 9/15/2023178,200 shares $74,844.00 +76.1%N/A3.3 $0.42Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 8/31/2023101,200 shares $46,248.40 -8.9%N/A2 $0.46 8/15/2023111,100 shares $59,216.30 -4.4%N/A1.7 $0.53 7/31/2023116,200 shares $65,072.00 -16.6%N/A0.3 $0.56 7/15/2023139,400 shares $82,106.60 -13.6%N/A0.4 $0.59 6/30/2023161,300 shares $84,037.30 -28.7%N/A0.4 $0.52 6/15/2023226,300 shares $149,358.00 -40.4%3.0%0.5 $0.66 5/31/2023379,900 shares $246,593.09 -43.6%5.1%0.7 $0.65 5/15/2023673,100 shares $567,086.75 +358.5%9.0%1.2 $0.84 4/30/2023146,800 shares $104,183.96 -34.2%N/A0.4 $0.71 4/15/2023223,100 shares $172,980.59 +195.9%N/A0.5 $0.78 3/31/202375,400 shares $71,343.48 -7.6%N/A0.2 $0.95 3/15/202381,600 shares $89,760.00 -75.9%N/A0.3 $1.10 2/28/2023338,700 shares $694,335.00 +149.8%N/A1.1 $2.05 2/15/2023135,600 shares $203,400.00 -55.2%N/A0.5 $1.50 1/31/2023302,400 shares $323,568.00 +484.9%N/A1.3 $1.07 1/15/202351,700 shares $44,979.00 +28.0%N/A0.3 $0.87 12/30/202240,400 shares $25,456.08 +15.8%0.5%0.3 $0.63 12/15/202234,900 shares $21,149.40 -25.3%0.9%0.3 $0.61 11/30/202246,700 shares $35,954.33 -57.4%1.6%0.3 $0.77 11/15/2022109,700 shares $89,416.47 +247.2%3.6%0.7 $0.82 10/31/202231,600 shares $26,860.00 -41.6%0.6%0.2 $0.85 10/15/202254,100 shares $43,280.00 -43.1%0.9%0.2 $0.80 9/30/202295,100 shares $76,060.98 +37.0%1.7%0 $0.80 9/15/202269,400 shares $66,624.00 -46.7%1.2%0 $0.96 8/31/2022130,300 shares $140,724.00 -11.2%2.3%0 $1.08 8/15/2022146,800 shares $204,052.00 -30.0%2.6%0.1 $1.39 7/31/2022209,800 shares $242,885.46 +11,555.6%3.4%0.1 $1.16 7/15/20221,800 shares $1,781.46 -71.9%0.0%0 $0.99 6/30/20226,400 shares $7,360.00 +106.5%0.1%0.2 $1.15 6/15/20223,100 shares $10,571.00 +29.2%0.1%0.1 $3.41 5/31/20222,400 shares $9,048.00 +2,300.0%0.0%0.5 $3.77 5/15/2022100 shares $417.00 -80.0%N/A0 $4.17 4/30/2022500 shares $2,590.00 +25.0%N/A0.2 $5.18 4/15/2022400 shares $1,754.76 +300.0%N/A0.1 $4.39 3/31/2022100 shares $508.00 -50.0%N/A0 $5.08 3/15/2022200 shares $908.00 No ChangeN/A0.1 $4.54 2/28/2022200 shares $1,062.00 No ChangeN/A0 $5.31 2/15/2022200 shares $1,139.80 -93.3%N/A0 $5.70 1/31/20223,000 shares $17,190.00 +500.0%0.1%0.7 $5.73 1/15/2022500 shares $2,985.00 -96.4%0.0%0.1 $5.97 12/31/202113,800 shares $86,802.00 +885.7%0.3%4.3 $6.29 12/15/20211,400 shares $9,114.00 -12.5%0.0%0.5 $6.51 11/30/20211,600 shares $11,216.00 +6.7%0.0%0.8 $7.01 11/15/20211,500 shares $12,060.00 +87.5%0.0%0.8 $8.04 10/29/2021800 shares $6,312.00 -11.1%0.0%0.4 $7.89 10/15/2021900 shares $7,659.00 -25.0%0.0%0.4 $8.51 9/30/20211,200 shares $10,812.00 -63.6%0.0%0.3 $9.01 9/15/20213,300 shares $32,043.00 -13.2%0.1%0.8 $9.71 8/31/20213,800 shares $36,974.00 +111.1%0.1%0.8 $9.73 8/13/20211,800 shares $17,874.00 +157.1%0.0%0.4 $9.93Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 7/30/2021700 shares $6,895.00 -69.6%0.0%0.1 $9.85 7/15/20212,300 shares $22,195.00 +1,050.0%N/A0.4 $9.65 6/30/2021200 shares $1,912.00 -96.0%N/A0 $9.56 6/15/20215,000 shares $55,000.00 +354.6%N/A0.7 $11.00 5/28/20211,100 shares $10,285.11 -73.2%N/A0.2 $9.35 5/14/20214,100 shares $37,064.00 -43.1%N/A0.4 $9.04 4/30/20217,200 shares $71,928.00 +200.0%N/A0.4 $9.99 4/15/20212,400 shares $25,128.00 +140.0%N/A0.1 $10.47 3/31/20211,000 shares $10,400.00 -47.4%N/A0 $10.40 3/15/20211,900 shares $20,501.00 -71.2%N/A0 $10.79 2/26/20216,600 shares $74,580.00 +57.1%N/A0.1 $11.30 2/12/20214,200 shares $47,880.00 -67.9%N/A0 $11.40 1/29/202113,100 shares $144,755.00 +1,090.9%N/A0.1 $11.05 1/15/20211,100 shares $11,814.00 No ChangeN/A0 $10.74 ADXN Short Interest - Frequently Asked Questions What is Addex Therapeutics' current short interest? Short interest is the volume of Addex Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 2,900 shares of ADXN short. 0.35% of Addex Therapeutics' shares are currently sold short. Learn More on Addex Therapeutics' current short interest. What is a good short interest percentage for Addex Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.35% of Addex Therapeutics' floating shares are currently sold short. Is Addex Therapeutics' short interest increasing or decreasing? Addex Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,900 shares, an increase of 45.0% from the previous total of 2,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Addex Therapeutics' float size? Addex Therapeutics currently has issued a total of 1,060,000 shares. Some of Addex Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Addex Therapeutics currently has a public float of 819,300 shares. How does Addex Therapeutics' short interest compare to its competitors? 0.35% of Addex Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Addex Therapeutics: bluebird bio, Inc. (4.42%), Kezar Life Sciences, Inc. (1.11%), FibroGen, Inc. (3.72%), Marinus Pharmaceuticals, Inc. (3.95%), MiNK Therapeutics, Inc. (2.29%), Allakos Inc. (0.37%), Scilex Holding (5.79%), CalciMedica, Inc. (1.09%), Surrozen, Inc. (0.90%), Generation Bio Co. (2.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Addex Therapeutics stock? Short selling ADXN is an investing strategy that aims to generate trading profit from Addex Therapeutics as its price is falling. ADXN shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Addex Therapeutics? A short squeeze for Addex Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADXN, which in turn drives the price of the stock up even further. How often is Addex Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADXN, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies BLUE Short Interest Data KZR Short Interest Data FGEN Short Interest Data MRNS Short Interest Data INKT Short Interest Data ALLK Short Interest Data SCLX Short Interest Data CALC Short Interest Data SRZN Short Interest Data GBIO Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADXN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
